These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 15788057)

  • 1. Sirolimus-eluting stent implantation for chronic total occlusion of the left main coronary artery.
    Aoki J; Hoye A; Staferov AV; Alekyan BG; Serruys PW
    J Interv Cardiol; 2005 Feb; 18(1):65-9; discussion 69. PubMed ID: 15788057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY; Park DW; Yun SC; Lee SW; Kim YH; Lee CW; Hong MK; Park SW; Park SJ
    J Am Coll Cardiol; 2009 Aug; 54(9):853-9. PubMed ID: 19695467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of drug-eluting stent implantation for patients with unprotected left main coronary artery stenosis.
    Kim YH; Dangas GD; Solinas E; Aoki J; Parise H; Kimura M; Franklin-Bond T; Dasgupta NK; Kirtane AJ; Moussa I; Lansky AJ; Collins M; Stone GW; Leon MB; Moses JW; Mehran R
    Am J Cardiol; 2008 Mar; 101(6):801-6. PubMed ID: 18328844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sirolimus-eluting stent implantation for ostial stenosis of left main coronary artery after Bentall operation in aortitis syndrome.
    Terasawa A; Kondo K; Ishikawa S; Morimoto R; Tajika T; Hayashi Y
    J Cardiol; 2010 Jan; 55(1):147-50. PubMed ID: 20122564
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective registry to evaluate sirolimus-eluting stents implanted at coronary bifurcation lesions using the "crush technique".
    Moussa I; Costa RA; Leon MB; Lansky AJ; Lasic Z; Cristea E; Trubelja N; Carlier SG; Mehran R; Dangas GD; Weisz G; Kreps EM; Collins M; Stone GW; Moses JW
    Am J Cardiol; 2006 May; 97(9):1317-21. PubMed ID: 16635603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Percutaneous stenting of chronic total occlusion of unprotected left main coronary artery.
    Trehan V; Mehta V; Mukhopadhyay S; Yusuf J; Arora R
    Indian Heart J; 2003; 55(2):172-4. PubMed ID: 12921334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of unprotected left main coronary artery stenosis in the drug-eluting stent era.
    Tanigawa J; Sutaria N; Goktekin O; Di Mario C
    J Interv Cardiol; 2005 Dec; 18(6):455-65. PubMed ID: 16336426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integrated coronary revascularization with drug-eluting stents: immediate and seven-month outcome.
    Vassiliades TA; Douglas JS; Morris DC; Block PC; Ghazzal Z; Rab ST; Cates CU
    J Thorac Cardiovasc Surg; 2006 May; 131(5):956-62. PubMed ID: 16678575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unprotected left main coronary artery bifurcation stenosis: impact of plaque debulking prior to single sirolimus-eluting stent implantation.
    Tanaka N; Terashima M; Kinoshita Y; Kimura M; Nasu K; Ehara M; Tsuchikane E; Matsubara T; Asakura Y; Katoh O; Suzuki T
    J Invasive Cardiol; 2008 Oct; 20(10):505-10. PubMed ID: 18829993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The clinical outcome of percutaneous treatment of bifurcation lesions in multivessel coronary artery disease with the sirolimus-eluting stent: insights from the Arterial Revascularization Therapies Study part II (ARTS II).
    Tsuchida K; Colombo A; Lefèvre T; Oldroyd KG; Guetta V; Guagliumi G; von Scheidt W; Ruzyllo W; Hamm CW; Bressers M; Stoll HP; Wittebols K; Donohoe DJ; Serruys PW
    Eur Heart J; 2007 Feb; 28(4):433-42. PubMed ID: 17267457
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Favorable long-term outcome after drug-eluting stent implantation in nonbifurcation lesions that involve unprotected left main coronary artery: a multicenter registry.
    Chieffo A; Park SJ; Valgimigli M; Kim YH; Daemen J; Sheiban I; Truffa A; Montorfano M; Airoldi F; Sangiorgi G; Carlino M; Michev I; Lee CW; Hong MK; Park SW; Moretti C; Bonizzoni E; Rogacka R; Serruys PW; Colombo A
    Circulation; 2007 Jul; 116(2):158-62. PubMed ID: 17576862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stent-supported percutaneous coronary intervention for chronic total coronary occlusion.
    Migliorini A; Moschi G; Vergara R; Parodi G; Carrabba N; Antoniucci D
    Catheter Cardiovasc Interv; 2006 Mar; 67(3):344-8. PubMed ID: 16489559
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Simultaneous subacute stent thrombosis after implantation of sirolimus-eluting stent and bare-metal stent.
    Kang WC; Moon CI; Ahn TH; Shin EK
    Int J Cardiol; 2008 Jul; 127(2):e89-92. PubMed ID: 17689731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kissing sirolimus-eluting stents for the treatment of left main coronary artery stenosis.
    Cox N; Rogers C
    Catheter Cardiovasc Interv; 2004 Feb; 61(2):206-10. PubMed ID: 14755813
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single-vessel versus bifurcation stenting for the treatment of distal left main coronary artery disease in the drug-eluting stenting era. Clinical and angiographic insights into the Rapamycin-Eluting Stent Evaluated at Rotterdam Cardiology Hospital (RESEARCH) and Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registries.
    Valgimigli M; Malagutti P; Rodriguez Granillo GA; Tsuchida K; Garcia-Garcia HM; van Mieghem CA; Van der Giessen WJ; De Feyter P; de Jaegere P; Van Domburg RT; Serruys PW
    Am Heart J; 2006 Nov; 152(5):896-902. PubMed ID: 17070153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left main coronary artery disease: is CABG still the gold standard?
    Ng MK; Yeung AC
    Rev Cardiovasc Med; 2005; 6(4):187-93. PubMed ID: 16379014
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short and long-term outcomes of two drug eluting stents in bifurcation lesions.
    Chen JL; Gao RL; Yang YJ; Qiao SB; Qin XW; Yao M; Xu B; Liu HB; Wu YJ; Yuan JQ; Chen J; Wu Y; Dai J
    Chin Med J (Engl); 2007 Feb; 120(3):183-6. PubMed ID: 17355818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized comparison of sirolimus-eluting stent versus standard stent for percutaneous coronary revascularization in diabetic patients: the diabetes and sirolimus-eluting stent (DIABETES) trial.
    Sabaté M; Jiménez-Quevedo P; Angiolillo DJ; Gómez-Hospital JA; Alfonso F; Hernández-Antolín R; Goicolea J; Bañuelos C; Escaned J; Moreno R; Fernández C; Fernández-Avilés F; Macaya C;
    Circulation; 2005 Oct; 112(14):2175-83. PubMed ID: 16203930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term outcomes following drug-eluting stent implantation in unprotected left main bifurcation lesions.
    Ge L; Cosgrave J; Iakovou I; Qian JY; Agostoni P; Sangiorgi GM; Airoldi F; Michev I; Chieffo A; Corvaja N; Colombo A; Ge JB
    Chin Med J (Engl); 2007 Apr; 120(7):545-51. PubMed ID: 17442200
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multi-lesion culotte and crush bifurcation stenting with sirolimus-eluting stents: long-term angiographic outcome.
    Daemen J; Lemos PA; Serruys PW
    J Invasive Cardiol; 2003 Nov; 15(11):653-6. PubMed ID: 14608139
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.